Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 12, 2025 • 4:30 AM ET

Date/Time Source News Release
10/05/2023 08:00 AM EDT GlobeNewswire Paratek Pharmaceuticals to Present NUZYRA Data at IDWeek 2023
09/21/2023 08:58 AM EDT GlobeNewswire Gurnet Point Capital and Novo Holdings A/S Complete Acquisition of Paratek Pharmaceuticals, Inc.
09/18/2023 09:37 AM EDT GlobeNewswire Paratek Pharmaceuticals Announces Stockholder Approval of Acquisition by Gurnet Point Capital and Novo Holdings A/S
09/12/2023 07:30 AM EDT GlobeNewswire Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Paratek Pharmaceuticals Stockholders Vote FOR the Acquisition by Gurnet Point Capital and Novo Holdings A/S
09/10/2023 08:06 AM EDT GlobeNewswire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HCCI, KLR, PRTK
09/07/2023 03:34 PM EDT GlobeNewswire Leading Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote FOR the Acquisition by Gurnet Point Capital and Novo Holdings
08/28/2023 01:37 PM EDT PR Newswire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, NEWR, PRTK
08/27/2023 12:06 AM EDT GlobeNewswire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CEQP, CELL, DINO, PRTK
08/09/2023 11:09 PM EDT PR Newswire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TRTN, AMED, PRTK
08/03/2023 08:00 AM EDT GlobeNewswire Paratek Pharmaceuticals Announces Second Quarter 2023 Revenue of $40.0 Million
Page

Additional News

As of June 12, 2025 • 4:30 AM ET

Date/Time Source News Release
11/02/2023 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, November 2nd, 2023
11/02/2023 06:56 AM EDT US Earnings Reports Expected earnings - Paratek Pharmaceuticals Inc.
08/23/2023 04:20 AM EDT ACCESSWIRE IA SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, PRTK
08/03/2023 10:02 AM EDT SeekingAlpha Paratek Pharmaceuticals GAAP EPS of -$0.25, revenue of $40M
08/03/2023 09:15 AM EDT Zacks Paratek Pharmaceuticals (PRTK) Reports Q2 Loss, Tops Revenue Estimates
07/12/2023 05:35 PM EDT ACCESSWIRE IA SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KDNY, PRTK, SGTX, KLR
07/11/2023 06:25 PM EDT SeekingAlpha NexPoint sends demand letter to Paratek Pharma for books & records on proposed takeover
06/27/2023 01:48 PM EDT SeekingAlpha Paratek antibiotic Nuzyra to receive EU orphan drug status
06/27/2023 01:05 PM EDT SeekingAlpha Paratek investor NexPoint warns it may vote against takeover deal
06/18/2023 10:15 AM EDT ACCESSWIRE IA SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VECT, AAIC, PRTK, NEX
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.